Non-alcoholic fatty liver disease (NAFLD) is a metabolic stress liver injury that is closely
related to obesity, insulin resistance, type 2 diabetes, atherosclerosis, and metabolic …

Mitochondrial abnormalities in the brain are considered early pathological changes in
neurogenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD) and …

Objective The aim of this trial was to characterize the beneficial effects of probiotics on
decreasing endotoxin levels and other cardiometabolic parameters in Arab patients with …

Western diet (WD) is one of the major culprits of metabolic disease including type 2 diabetes
(T2D) with gut microbiota playing an important role in modulating effects of the diet. Herein …

Objectives The beneficial effects of pro-, pre-, and synbiotics on obesity with insulin
resistance have been reported previously. However, the strain-specific effect of probiotics …

Recent evidence demonstrates potential links between mitochondrial dysfunction and
inflammatory bowel diseases (IBD). In addition, bidirectional interactions between the …

The morbidity and mortality from cardiovascular diseases (CVD) remain high. Metabolic
diseases such as obesity, hyperlipidemia, diabetes mellitus (DM), non-alcoholic fatty liver …

Humans, throughout the life cycle, from birth to death, are accompanied by the presence of
gut microbes. Environmental factors, lifestyle, age and other factors can affect the balance of …

Probiotics can prevent obesity and related metabolic complications. In our study, the
protective effect and molecular mechanism of Lactobacillus rhamnosus JL1 (separated from …

Gut dysbiosis in diabetes mellitus is associated with decreased short-chain fatty acids and
epithelial barrier disruption. Microbial-derived toxins move across the “leaky gut” and incur …